World's Best Scientists 2026 revealed!
Guido Ferlazzo

Guido Ferlazzo

D-Index & Metrics

Immunology

D-Index
57
Citations
13119
World Ranking
3605
National Ranking
146

Overview

Guido Ferlazzo is affiliated with the University of Messina in Italy. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with significant contributions in Immunology, Oncology, Pulmonary and Respiratory Medicine, Infectious Diseases, and Surgery.

The main topics of their work include:

  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • IL-33, ST2, and ILC Pathways
  • Eosinophilic Esophagitis
  • Immune cells in cancer
  • T-cell and B-cell Immunology
  • SARS-CoV-2 and COVID-19 Research

Guido Ferlazzo has published scientific papers in a range of established venues. Their frequent publication venues are:

  • Frontiers in Immunology
  • European Journal of Immunology
  • Immunology Letters
  • Hepatology
  • Cancers

Some recent papers include:

  • Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade (2022, Frontiers in Immunology)
  • Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations (2020, Expert Review of Vaccines)
  • Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer (2020, Frontiers in Immunology)
  • Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15 (2020, European Journal of Immunology)
  • Chitosan-Hyaluronan Nanoparticles for Vinblastine Sulfate Delivery: Characterization and Internalization Studies on K-562 Cells (2022, Pharmaceutics)

Frequent collaborators in research include:

  • Claudia De Pasquale
  • Stefania Campana
  • Paolo Carrega
  • Gaetana Pezzino
  • Riccardo Cavaliere

Best Publications

  • Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.

    Guido Ferlazzo;Ming L. Tsang;Lorenzo Moretta;Lorenzo Moretta;Giovanni Melioli

  • The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic

    Guido Ferlazzo;Dolca Thomas;Shao Lee Lin;Kiera Goodman

  • Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs.

    Guido Ferlazzo;Maggi Pack;Dolca Thomas;Casper Paludan

  • CD56brightCD16− Killer Ig-Like Receptor− NK Cells Display Longer Telomeres and Acquire Features of CD56dim NK Cells upon Activation

    Chiara Romagnani;Kerstin Juelke;Michela Falco;Barbara Morandi

  • NK cells at the interface between innate and adaptive immunity

    A Moretta;E Marcenaro;S Parolini;G Ferlazzo

  • Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells

    Paolo Carrega;Barbara Morandi;Roberta Costa;Guido Frumento

  • NK Cell Compartments and Their Activation by Dendritic Cells

    Guido Ferlazzo;Christian Münz

  • Effector and regulatory events during natural killer-dendritic cell interactions.

    Lorenzo Moretta;Lorenzo Moretta;Guido Ferlazzo;Cristina Bottino;Massimo Vitale

  • The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.

    Mariella Della Chiesa;Massimo Vitale;Simona Carlomagno;Guido Ferlazzo

  • CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells

    Kerstin Juelke;Monica Killig;Merlin Luetke-Eversloh;Eliana Parente

  • NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.

    Paolo Carrega;Fabrizio Loiacono;Emma Di Carlo;Angelo Scaramuccia

  • The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells.

    Guido Ferlazzo;Barbara Morandi;Antonella D'Agostino;Raffaella Meazza

  • The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer

    Antonino Bruno;Chiara Focaccetti;Arianna Pagani;Andrea S. Imperatori

  • CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph.

    Paolo Carrega;Irene Bonaccorsi;Emma Di Carlo;Barbara Morandi

  • Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application

    Nadia Sessarego;Alessia Parodi;Marina Podestà;Federica Benvenuto

  • Natural killer cell distribution and trafficking in human tissues.

    Paolo Carrega;Guido Ferlazzo

  • NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN‐γ secretion

    Barbara Morandi;Gwenola Bougras;William A. Muller;Guido Ferlazzo;Guido Ferlazzo

  • Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells

    Guido Ferlazzo;Barbara Morandi

  • A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis

    Antonino Bruno;Guido Ferlazzo;Adriana Albini;Douglas M. Noonan

  • The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production

    Stefania Laurent;Paola Queirolo;Silvia Boero;Sandra Salvi

Frequent Co-Authors

Lorenzo Moretta
Lorenzo Moretta Bambino Gesù Children's Hospital
Maria Cristina Mingari
Maria Cristina Mingari University of Genoa
Alessandro Moretta
Alessandro Moretta University of Genoa
Christian Münz
Christian Münz University of Zurich
Claudia Cantoni
Claudia Cantoni University of Genoa
Cristina Bottino
Cristina Bottino University of Genoa
Daniela Pende
Daniela Pende University of Genoa
Michela Falco
Michela Falco Istituto Giannina Gaslini
Adriana Albini
Adriana Albini University of Milano-Bicocca
Katia Georgopoulos
Katia Georgopoulos Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse career opportunities, especially in healthcare and research. Many students interested in immunology also explore online degrees that complement their knowledge, such as nursing programs designed for various entry points.

For those without prior healthcare experience, the best online bsn programs for non nurses offer a flexible path to become a registered nurse while building foundational medical knowledge that benefits immunology applications.

If accelerating your nursing career is a priority, considering the easiest accelerated nursing programs to get into can provide a quicker route to gaining critical skills needed for patient care in immunology-related fields.

Entry-level licensing is another viable route. Many students start with practical nursing through lpn schools easy to get into, which helps establish a solid clinical foundation.

For advanced practice roles, exploring the easiest np programs to get into allows students to elevate their expertise and contribute more directly to immunology research and patient care.

These related programs illustrate how dynamic and versatile career pathways connected to immunology can be, especially when combined with online education options that cater to different backgrounds and schedules.

Best Scientists Citing Guido Ferlazzo

Trending Scientists

Recently Published Articles